Myeloid neoplasms with germline DDX41 mutation
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2017/05/25
-
Indian UGC (journal)
-
Refrences72
-
Citations66
-
Jesse J. C. Cheah
-
Christopher N. Hahn
-
Devendra K. Hiwase
-
Hamish S. Scott ORCID (unauthenticated)
-
Anna L. Brown
Cite
Cheah, Jesse J. C., et al. “Myeloid Neoplasms With Germline DDX41 Mutation”. International Journal of Hematology, vol. 106, no. 2, 2017, pp. 163-74, https://doi.org/10.1007/s12185-017-2260-y.
Cheah, J. J. C., Hahn, C. N., Hiwase, D. K., Scott, H. S., & Brown, A. L. (2017). Myeloid neoplasms with germline DDX41 mutation. International Journal of Hematology, 106(2), 163-174. https://doi.org/10.1007/s12185-017-2260-y
Cheah JJC, Hahn CN, Hiwase DK, Scott HS, Brown AL. Myeloid neoplasms with germline DDX41 mutation. International Journal of Hematology. 2017;106(2):163-74.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the blood and blood-forming organs
Medicine
Medicine (General)
You May Also Like
- Mechanism of thrombocytopenia in COVID-19 patients
- Epidemiology of non-Hodgkin?s lymphoma (NHL): trends, geographic distribution, and etiology
- The IgG Fc receptor family
- Renal failure in multiple myeloma: reversibility and impact on the prognosis
- Erythropoietin after a century of research: younger than ever
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| 10.1074/jbc.M116.772327 | Journal of Biological Chemistry |
| 2017 | |
How I manage ibrutinib-refractory chronic lymphocytic leukemia | Blood Journal |
| 38 | 2017 |
Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms | Blood Journal |
| 133 | 2017 |
| Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures | Trends in Genetics |
| 43 | 2017 |
| Preleukemia: one name, many meanings | Leukemia |
| 43 | 2017 |
Refrences Analysis
The category
Science: Biology (General): Genetics 19
is the most frequently represented among the references in this article. It primarily includes studies from Haematologica The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders | Best Practice & Research Clinical Haematology |
| 2024 | |
Impaired binding affinity of YTHDC1 with METTL3/METTL14 results in R-loop accumulation in myelodysplastic neoplasms with DDX41 mutation | Leukemia |
| 2024 | |
Hereditary predisposition syndromes to myeloid neoplasms: diseases, genes and mechanisms of development | Oncohematology |
| 2024 | |
Rare Hematologic Malignancies and Pre-Leukemic Entities in Children and Adolescents Young Adults | Cancers |
| 2024 | |
Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome | International Journal of Molecular Sciences |
| 2024 |
Citations Analysis
The category
Medicine: Medicine (General) 50
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Familial predisposition of myeloid malignancies: biological and clinical significance of recurrent germ line mutations and was published in 2017. The most recent citation comes from a 2024 study titled Hereditary predisposition syndromes to myeloid neoplasms: diseases, genes and mechanisms of development. This article reached its peak citation in 2022, with 14 citations. It has been cited in 40 different journals, 27% of which are open access. Among related journals, the Frontiers in Oncology cited this research the most, with 6 citations. The chart below illustrates the annual citation trends for this article.